Reoperation for post-hepatectomy hemorrhage: increased risk of mortality
Tóm tắt
Reoperation for post-hepatectomy hemorrhage (PHH) represents an important complication in patients undergoing liver resection. Yet, few studies have reported its presentation and patient outcomes of this event. Among the 2,086 patients who underwent elective hepatectomy from 2000 to 2009 in our HPB unit, the perioperative data of 12 (0.6 %) patients who underwent re-laparotomy for PHH were retrospectively analyzed. The diagnosis of PHH was established in all cases by the presence of blood in the drain. The mean interval time between the end of liver resection and the diagnosis of bleeding and reoperation were 17 h (1–43) and 38 h (1–93), respectively. The causes of bleeding were the hepatic vein branch (n = 4), liver cut surface (n = 3), and a hepatic artery branch (n = 2). In three cases, no bleeding spot was identified. Postoperative death occurred in 3 patients (25 %) between 15 and 18 days after re-laparotomy. These 3 patients were all cirrhotic; 2 underwent early re-laparotomy (≤6 h) and 1 underwent re-laparotomy 24 h after the first recognition of active bleeding. Reoperation for PHH remains an important morbid event after liver resection. Death in patients with this complication is considerably high. It is diagnosed mainly on the aspect of the abdominal drain, justifying its use in risky patients.
Tài liệu tham khảo
Jamieson GG, Corbel L, Campion JP, Launois B (1992) Major liver resection without a blood transfusion: is it a realistic objective? Surgery 112(1):32–6
Melendez JA, Arslan V, Fischer ME et al (1998) Perioperative outcomes of major hepatic resections under low central venous pressure anesthesia: blood loss, blood transfusion, and the risk of postoperative renal dysfunction. J Am Coll Surg 187(6):620–5
Poon RT, Fan ST (2004) Hepatectomy for hepatocellular carcinoma: patient selection and postoperative outcome. Liver Transpl 10(2 Suppl 1):S39–45
Rahbari NN, Koch M, Zimmermann JB et al (2011) Infrahepatic inferior vena cava clamping for reduction of central venous pressure and blood loss during hepatic resection: a randomized controlled trial. Ann Surg 253(6):1102–10
Boonstra EA, Molenaar IQ, Porte RJ, de Boer MT (2009) Topical haemostatic agents in liver surgery: do we need them? HPB (Oxford) 11(4):306–10
Figueras J, Llado L, Miro M et al (2007) Application of fibrin glue sealant after hepatectomy does not seem justified: results of a randomized study in 300 patients. Ann Surg 245(4):536–42
Belghiti J, Hiramatsu K, Benoist S et al (2000) Seven hundred forty-seven hepatectomies in the 1990s: an update to evaluate the actual risk of liver resection. J Am Coll Surg 191(1):38–46
Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240(2):205–13
Balzan S, Belghiti J, Farges O et al (2005) The "50-50 criteria" on postoperative day 5: an accurate predictor of liver failure and death after hepatectomy. Ann Surg 242(6):824-8–828-9
Yang T, Li L, Zhong Q et al (2013) Risk factors of hospital mortality after re-laparotomy for post-hepatectomy hemorrhage. World J Surg 37(10):2394–401
Jarnagin WR, Gonen M, Fong Y et al (2002) Improvement in perioperative outcome after hepatic resection: analysis of 1,803 consecutive cases over the past decade. Ann Surg 236(4):397–406, 406-7
Schroeder RA, Marroquin CE, Bute BP et al (2006) Predictive indices of morbidity and mortality after liver resection. Ann Surg 243(3):373–9
Teh SH, Nagorney DM, Stevens SR et al (2007) Risk factors for mortality after surgery in patients with cirrhosis. Gastroenterology 132(4):1261–9
Friedman LS (1999) The risk of surgery in patients with liver disease. Hepatology 29(6):1617–23
Gelman S (1987) General anesthesia and hepatic circulation. Can J Physiol Pharmacol 65(8):1762–79
Frilling A, Stavrou GA, Mischinger HJ et al (2005) Effectiveness of a new carrier-bound fibrin sealant versus argon beamer as haemostatic agent during liver resection: a randomised prospective trial. Langenbecks Arch Surg 390(2):114–20
Schwartz M, Madariaga J, Hirose R et al (2004) Comparison of a new fibrin sealant with standard topical hemostatic agents. Arch Surg 139(11):1148–54